Overview
Dr. Donner's clinical and research interests have focused on the prevention of complications in patients with type 1 and 2 diabetes. For 6 years, he was the Associate Medical Director of the Joslin Diabetes Center affiliate at the University of Maryland, and then Medical Director from 2004 - 2010. After joining the faculty at Johns Hopkins University in 2010, his clinical and research interests became fully dedicated to diabetes. He became the Director of The Johns Hopkins Diabetes Center in 2011. He has been a clinical investigator in a number of NIH- and industry-funded diabetes research trials. Dr. Donner was a co-PI in the NIH-funded Veterans Affairs Implantable Insulin Pump Study, a Co-PI on the NIDDK-funded Diabetes Control and Complications Trial / Epidemiology of Diabetes Intervention and Complications (DCCT / EDIC) Study for 16 years, and Co-PI for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) for 7 years. Recently, he has served as PI for the Durable-response therapy Evaluation For Early or New-onset type 1 Diabetes (DEFEND-1). Dr. Donner is currently collaborating with Dr. Abdel Hamad in Immunology on preventing B-regulatory cell apoptosis using a novel monoclonal antibody targeting the presumptive apoptotic factor. This antibody prevents the development of type 1 diabetes in non obese diabetic mice. Dr. Donner is the PI for Johns Hopkins for TrialNet, a multicenter, international consortium of investigators studying ways to prevent Type 1 diabetes and preserve insulin secretion in individuals with newly diagnosed Type 1 diabetes. He is also a PI for a study investigating FIAsp, a faster-acting insulin aspart in subjects with type 1 diabetes, and is working with investigators at the Johns Hopkins School of Engineering on an implantable insulin pump which delivers insulin intravenously.
Dr. Donner is highly rated in 5 conditions, according to our data. His clinical expertise encompasses Diabetic Nephropathy, Type 1 Diabetes (T1D), Type 2 Diabetes (T2D), and Diabetic Neuropathy.
Dr. Donner is board certified in American Board Of Internal Medicine. He is actively involved in clinical research, co-authoring 2 peer reviewed articles. Dr. Donner is currently accepting new patients.
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- INSURANCE PLAN
- MEDICARE PDP
- PPO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE SNP
- OTHER MEDICARE PART D
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE-MEDICAID PLAN
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE ASSISTANCE PROGRAM
- MEDICARE MAPD
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
10751 Falls Road, Falls Concourse STE 412, Lutherville, MD 21093
Additional Areas of Focus
Dr. Donner has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Johns Hopkins Outpatient Center
Roberto Salvatori is an Endocrinologist practicing medicine in Baltimore, Maryland. Dr. Salvatori is highly rated in 43 conditions, according to our data. His clinical expertise encompasses Growth Hormone Deficiency (GHD), Hypopituitarism, Pituitary Tumor, Cushing's syndrome, and Hormone Replacement Therapy (HRT). Dr. Salvatori is currently accepting new patients.
Johns Hopkins Health Care & Surgery Center - Green Spring Station, Lutherville
Dr. Douglas Ball is an associate professor of medicine at the Johns Hopkins University School of Medicine. He holds a joint appointment in oncology. His areas of clinical expertise include diagnostic radiology, endocrine oncology, thyroid cancer and thyroid diseases. Dr. Ball earned his M.D. from the George Washington University School of Medicine. He completed his residency at the University of Pittsburgh-Presbyterian University Hospital and performed a fellowship in endocrinology and metabolism at Johns Hopkins. His research interests include medullary thyroid cancer, differentiated thyroid cancer and anaplastic thyroid cancer. Dr. Ball is highly rated in 19 conditions, according to our data. His clinical expertise encompasses Medullary Thyroid Carcinoma, Thyroid Cancer, Anaplastic Thyroid Cancer, and Papillary Thyroid Cancer. Dr. Ball is board certified in American Board Of Internal Medicine. Dr. Ball is currently accepting new patients.
Johns Hopkins Outpatient Center
Amir Hamrahian, M.D. is an endocrinologist with specialized experience in the treatment of adrenal and pituitary disorders. Dr. Hamrahian is located in Baltimore, Maryland. He received his medical degree from Hacettepe University in Ankara, Turkey, did his internal medicine residency at the University of North Dakota and completed his endocrinology fellowship at the Case Western Reserve University. Dr. Hamrahian is an Associate Professor of Medicine and has published more than 80 peer-reviewed articles, and has served as a co-author in developing guidelines for adrenal and pituitary disorders. He has presented at national and international conferences and has served as the principal investigator for a number of clinical research studies. Accolades received include Teacher of The Year award and Human Subject Research Annual Professional Excellence award in 2003 and 2011, respectively. Dr. Hamrahian has held roles including the chief of endocrinology in Abu Dhabi. Dr. Hamrahian is a co-director of the Adrenal Center. Dr. Hamrahian is highly rated in 33 conditions, according to our data. His clinical expertise encompasses Cushing's disease, Pituitary Tumor, Cushing's syndrome, Prolactinoma, and Gamma Knife Radiosurgery. Dr. Hamrahian is board certified in American Board Of Internal Medicine. Dr. Hamrahian is currently accepting new patients.
Frequently Asked Questions about Dr. Tom W. Donner
How do I make an appointment with Dr. Tom W. Donner?
You can book an appointment with Dr. Tom W. Donner by calling their office at 410-955-9270. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Tom W. Donner a top-rated expert for Diabetic Nephropathy?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Tom W. Donner is classified as an Distinguished expert for Diabetic Nephropathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Tom W. Donner specialize in?
While Dr. Tom W. Donner is a Endocrinology, they have specific expertise in Diabetic Nephropathy, Type 1 Diabetes (T1D), and Type 2 Diabetes (T2D). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Endocrinology.
Does Dr. Tom W. Donner participate in research or clinical trials?
Yes. Dr. Tom W. Donner has published 2 articles and abstracts on conditions like Diabetic Nephropathy. You can view a list of Dr. Tom W. Donner's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Tom W. Donner accept my insurance?
Dr. Tom W. Donner accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 410-955-9270 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Diabetic NephropathyDr. Donner isDistinguished. Learn about Diabetic Nephropathy.
- Type 1 Diabetes (T1D)Dr. Donner isDistinguished. Learn about Type 1 Diabetes (T1D).
- Advanced
- Diabetic NeuropathyDr. Donner isAdvanced. Learn about Diabetic Neuropathy.
- Maturity Onset Diabetes of the Young
- Type 2 Diabetes (T2D)Dr. Donner isAdvanced. Learn about Type 2 Diabetes (T2D).
- Experienced
- Adrenal Insufficiency PediatricDr. Donner isExperienced. Learn about Adrenal Insufficiency Pediatric.
- Diabetic RetinopathyDr. Donner isExperienced. Learn about Diabetic Retinopathy.
- Graves DiseaseDr. Donner isExperienced. Learn about Graves Disease.
- Obesity in ChildrenDr. Donner isExperienced. Learn about Obesity in Children.